08/31/2026
As the regulatory landscape evolves, how do we ensure innovation keeps moving forward while helping new medicines and health technologies reach patients safely?The UCSF School of Pharmacy is launching a new Master of Science in Regulatory Science and Digital Innovation (RSDI) to prepare professionals to meet that challenge.
“The regulatory field is changing as quickly as the science and technology it oversees,” said program director Liang Zhao. “We need professionals who can anticipate what’s coming and respond effectively.”
The program builds on the school’s long-standing strength in the field, including the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (since 2014). The program offers two tracks: an executive path for mid- to senior-level leaders looking to gain expertise in the global regulatory landscape and policy , and a foundational path for early-career professionals entering or pivoting into regulatory science, biotech, or digital health.
Students complete the degree in four to five quarters, combining rigorous coursework with a thesis or capstone. Industry leaders from companies such as Intuitive Surgical, Genentech, and Accumulus Technologies are helping to shape the program.
Applications open Sept. 1 and close Dec. 1. The first cohort begins July 2027.
Learn more: https://pharmacy.ucsf.edu/news/2026/08/new-masters-program-aims-to-shape-future-of-regulatory-science